Saudi Pharmaceutical Industries and Medical Appliances Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Saudi Pharmaceutical Industries and Medical Appliances Corporation's yearly results (2022–2025), compared with Healthcare companies in Saudi Arabia. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than 96% of Healthcare companies in Saudi Arabia.
- Profit Cash Ratio: Over the last 3 years, every SAR 100 of reported profit came with SAR -30 of operating cash. Lower than 96% of Healthcare companies in Saudi Arabia.
- Growth Efficiency Ratio: Sales grew 20% in 3 years; of every extra SAR 100 of sales, SAR 123 became extra profit. Higher than 96% of Healthcare companies in Saudi Arabia.
Where SAR 100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
SAR -30Over the last 3 years, every SAR 100 of reported profit came with SAR -30 of operating cash.
Lower than 96% of Healthcare companies in Saudi Arabia.
Self-Funding Ratio
-0.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 96% of Healthcare companies in Saudi Arabia.
Cash Locked Ratio
SAR 66For every SAR 100 of sales, SAR 66 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against SAR 49 tied up three years earlier.
More money tied up than 96% of Healthcare companies in Saudi Arabia.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 75% of Healthcare companies in Saudi Arabia.
Growth Efficiency Ratio
SAR 123Sales grew 20% in 3 years; of every extra SAR 100 of sales, SAR 123 became extra profit.
Higher than 96% of Healthcare companies in Saudi Arabia.
Asset Productivity Ratio
+20% / +14%In 3 years sales changed by +20% while total assets changed by +14%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
0.3×Debt due within a year is covered 0.3 times by its yearly operating cash.
Lower than 88% of Healthcare companies in Saudi Arabia.
Cash Cushion Ratio
−33%Debt, after subtracting cash, equals 33% of its market value (net debt).
Lower than 71% of Healthcare companies in Saudi Arabia.
Tangible Assets Ratio
97%Of every SAR 100 the company owns, SAR 97 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 68% of Healthcare companies in Saudi Arabia.
Tangible Net Worth Ratio
92%Of every SAR 100 of net worth, SAR 92 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 77% of Healthcare companies in Saudi Arabia.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Saudi Pharmaceutical Industries and Medical Appliances Corporation owes SAR 0.58 for every SAR 1 it owns. Net profit rose 651% in the year to Dec 2025.
Compared with Healthcare companies in Saudi Arabia · latest annual results Dec 2025.
P/E ratio
15.0Investors pay SAR 15.0 for every SAR 1 of Saudi Pharmaceutical Industries and Medical Appliances Corporation's yearly profit, higher than 54% of Healthcare companies in Saudi Arabia.
P/B ratio
1.90The share price is 1.90 times Saudi Pharmaceutical Industries and Medical Appliances Corporation's book value per share, lower than 62% of Healthcare companies in Saudi Arabia.
Market cap
SAR 3.2 BThe total market value of all of Saudi Pharmaceutical Industries and Medical Appliances Corporation's shares at today's price (share price × number of shares), smaller than 71% of Healthcare companies in Saudi Arabia. PosiCap size class: Mini Cap.
Net worth (book value)
SAR 1.7 BWhat Saudi Pharmaceutical Industries and Medical Appliances Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
SAR 14.15Net worth divided by the number of shares. The share price of SAR 26.82 is 1.9 times this, which is the P/B above.
Return on equity (ROE)
12.8%Saudi Pharmaceutical Industries and Medical Appliances Corporation earned 12.8% on its shareholders' money over the last year, lower than 59% of Healthcare companies in Saudi Arabia.
Owes vs Owns
0.58×Saudi Pharmaceutical Industries and Medical Appliances Corporation owes SAR 0.58 for every SAR 1 it owns (moderate), higher than 54% of Healthcare companies in Saudi Arabia.
Dividend yield
1.32%Saudi Pharmaceutical Industries and Medical Appliances Corporation pays 1.32% of its share price as dividends a year, lower than 96% of dividend-paying Healthcare companies in Saudi Arabia.
Revenue growth
+1%Revenue rose 1% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Profit growth
+651%Net profit rose 651% in the year to Dec 2025.
Profit margin
10.8%Saudi Pharmaceutical Industries and Medical Appliances Corporation keeps SAR 11 of every SAR 100 of revenue as net profit.
Cash quality
1.5×Cash from Saudi Pharmaceutical Industries and Medical Appliances Corporation's business was 1.5× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
2.5×Saudi Pharmaceutical Industries and Medical Appliances Corporation's operating profit covered its interest costs 2.5 times in the year to Dec 2025.
Cash vs debt
Net debtSaudi Pharmaceutical Industries and Medical Appliances Corporation had SAR 1.0 B more debt than cash (net debt) at Dec 2025.
Questions
What is Saudi Pharmaceutical Industries and Medical Appliances Corporation's P/E ratio?
Investors pay SAR 15.0 for every SAR 1 of Saudi Pharmaceutical Industries and Medical Appliances Corporation's yearly profit, higher than 54% of Healthcare companies in Saudi Arabia.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Saudi Pharmaceutical Industries and Medical Appliances Corporation: SAR 3.2 B ÷ SAR 1.7 B (30 Jun 2026) = 1.9.
What is Saudi Pharmaceutical Industries and Medical Appliances Corporation's return on equity?
Saudi Pharmaceutical Industries and Medical Appliances Corporation earned 12.8% on its shareholders' money over the last year, lower than 59% of Healthcare companies in Saudi Arabia.
How much does Saudi Pharmaceutical Industries and Medical Appliances Corporation owe compared with what it owns?
Saudi Pharmaceutical Industries and Medical Appliances Corporation owes SAR 0.58 for every SAR 1 it owns (moderate), higher than 54% of Healthcare companies in Saudi Arabia.
Does Saudi Pharmaceutical Industries and Medical Appliances Corporation pay a dividend?
Yes. Saudi Pharmaceutical Industries and Medical Appliances Corporation pays 1.32% of its share price as dividends a year, lower than 96% of dividend-paying Healthcare companies in Saudi Arabia.
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation's revenue growing?
Revenue rose 1% in the year to Dec 2025, and grew 6% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.